Perrigo Company and Tris Pharma announced the launch of Dextromethorphan Polistirex Oral Suspension, a store brand equivalent to Reckitt Benckiser‘s Delsym extended–release oral liquid suspension. It will be marketed under major U.S. retailer and wholesalers’ store brands or own label brands.
Delsym suspension, an over-the-counter (OTC) antitussive, is indicated for the treatment of nonproductive cough due to minor throat and bronchial irritation. This centrally-active antitussive acts in the CNS to increase the threshold for cough. While it does not provide analgesia, it does produce less GI adverse effects and does not cause drug dependence.
For more information call (800) 719-9260 or visit www.perrigo.com.